1 completed, 1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Quest Clinical Research: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MISP 60528 Pneumococcal Vaccination PCV15 - Heart Transplant Infection Prevention | Terminated | Montefiore Medical Center | 4 | 2021-06-10 | 2026-02-04 | |
| Bictegravir/Emtricitabine/Tenofovir Alafenide Plus Doravirine Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch - HIV-1-infection | Phase 4 | Completed | Quest Clinical Research | 20 | 2019-12-19 | 2024-03-05 |
bictegravir (1) · bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1) · emtricitabine tenofovir alafenamide (1)
United States (2)